Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Dias, Flávia Regina Cruz, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, Robert J. Carey, and Marinete Pinheiro Carrera. "Residual dopamine receptor desensitization following either high-or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine." Psychopharmacology 225, no. 1 (2013): 141-150. |
|
de Lange, Elizabeth CM. "Pharmacometrics in psychiatric diseases." In Applied Pharmacometrics, pp. 407-449. Springer, New York, NY, 2014. |
|
Robinson, Sarah B., Osama Refai, J. Andrew Hardaway, Sarah Sturgeon, Tessa Popay, Daniel P. Bermingham, Phyllis Freeman, Jane Wright, and Randy D. Blakely. "Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1." PloS one 14, no. 5 (2019): e0216417. |
|
Cardosa, Daniel, Joseph Wakeham, Philippa Amy Shaw, Brittany Dutton, and Levine Wildman. "Chlorpromazine versus thiothixene for people with schizophrenia (Protocol)." Cochrane Database of Systematic Reviews 9 (2017). |
|
Li, Zongchang, Ying He, Hongying Han, Yao Zhou, Xiaoqian Ma, Dong Wang, Jun Zhou et al. "COMT, 5-HTR2A, and SLC6A4 mRNA expressions in first-episode antipsychotic-naive schizophrenia and association with treatment outcomes." Frontiers in psychiatry 9 (2018): 577. |
|
Gründer, Gerhard, Philipp Bauknecht, Stefan Klingberg, Karolina Leopold, Michael Paulzen, Stefanie Schell, Katarina Stengler, and Stefan Leucht. "Treatment goals for patients with schizophrenia—a narrative review of physician and patient perspectives." Pharmacopsychiatry (2020). |
|
Schultze-Lutter, Frauke, and Benno G. Schimmelmann. "Psychotische Störungen im DSM-5: DSM-5 Kommentar." Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie 42, no. 3 (2014): 193-202. |
|
White, William Allen. "Antipsychotic agents." Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness (2012): 31. |
|
Grover, Sandeep, Swapnajeet Sahoo, and Aseem Mehra. "Perceptions of psychiatrists toward the use of long-acting injectable antipsychotics: an online survey study from India." Journal of clinical psychopharmacology 39, no. 6 (2019): 611-619. |
|
Alonso-Vega, Jesús, Miguel Núñez de Prado-Gordillo, Gladis Lee Pereira, and María Xesús Froján-Parga. "El tratamiento de Enfermedades Mentales Graves desde la investigación de procesos." (2019): 44-65. |
|
Blom, Jan Dirk, Bastiaan C. Ter Meulen, and Jitze Dool. "A century of prosopometamorphopsia studies." Cortex (2021). |
|
Bailliard, Antoine L., and Stephanie C. Whigham. "Linking neuroscience, function, and intervention: A scoping review of sensory processing and mental illness." American Journal of Occupational Therapy 71, no. 5 (2017): 7105100040p1-7105100040p18. |
|
Altamura, A. Carlo. "From'classical'antipsychotics to'multidimensional stabilizers': do we need a new classification for novel drugs used in schizophrenia?." Neuropsychiatry 1, no. 6 (2011): 541. |
|
Rakovska, Angelina, Daniel Javitt, Polina Petkova-Kirova, Andrea Balla, Rosalind Ang, and Reni Kalfin. "Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats." Brain research bulletin 153 (2019): 39-46. |
|
Okbay, Aysu. Essays on Genetics and the Social Sciences. No. EPS-2017-413-S&E. 2017. |
|
Svane, Kirsten C., Ericka-Kate Asis, Anton Omelchenko, Ansley J. Kunnath, Linda M. Brzustowicz, Steven M. Silverstein, and Bonnie L. Firestein. "D-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner." Molecular and Cellular Neuroscience 89 (2018): 20-32. |
|
Gatch, Michael B., Ritu A. Shetty, Nathalie Sumien, and Michael J. Forster. "Behavioral effects of four novel synthetic cathinone analogs in rodents." Addiction Biology 26, no. 4 (2021): e12987. |
|
van Rooy, Inge, Shin-Ying Wu, Gert Storm, Wim E. Hennink, Heike Dinter-Heidorn, Raymond M. Schiffelers, and Enrico Mastrobattista. "Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitors." International journal of pharmaceutics 416, no. 2 (2011): 448-452. |
|
Zamengo, Luca, Giampietro Frison, and Guus Zwitser. "Understanding and managing the new psychoactive substances phenomenon: a holistic approach." Journal of public health policy 40, no. 2 (2019): 217-235. |
|
Wang, Lien, Yan Zhang, Chaoran Wang, Xiuli Zhang, Zhiwei Wang, Xinmiao Liang, Amal Alachkar, and Olivier Civelli. "A Natural Product with High Affinity to Sigma and 5-HT 7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia." Neurochemical research 44, no. 11 (2019): 2536-2545. |
|